Delivery Order SPE2DB22D3011-SPE2DB23FQ2YP
Award Date 8/29/23
Potential Completion Date 8/30/23
Potential Value $13K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $13,776.32 to Amerisourcebergen Drug Corporation for the supply of 4561821756 MYRBETRIQ ER 50 MG TABLET 90S. Performance will take place in Conshohocken, Pennsylvania over one day from August 15 to August 16, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor. No major subcontractors or set aside designations were indicated....
- The Defense Logistics Agency awarded a $18,249 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 90 tablets of MYRBETRIQ ER 25 MG. To be performed in Conshohocken, Pennsylvania from August 4-7, 2023, this order is likely associated with DLA's Prime Vendor program to supply pharmaceuticals and medical supplies to military treatment facilities on behalf of the Department of Defense. As the prime contractor, Amerisourcebergen will deliver the specified quantity of the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $10,811.20 to Amerisourcebergen Drug Corporation for the supply of 4561543526 MYRBETRIQ ER 25 MG TABLET 90S. Amerisourcebergen Drug Corporation will perform as the prime contractor, with corporate oversight provided by its parent company, Amerisourcebergen Corporation. Performance will take place in Conshohocken, Pennsylvania over a one-day period from July 19, 2023 through July 20, 2023. The delivery order was...
- The Defense Logistics Agency awarded a $10,549.26 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561708661 MYRBETRIQ ER 50 MG TABLET 90S. The delivery order was issued under an existing prime vendor contract vehicle and calls for the contractor to deliver the specified pharmaceutical products to a location in Conshohocken, Pennsylvania by August 7, 2023 to support the Agency's medical supply needs. Amerisourcebergen will perform as the prime contractor...
- The Defense Logistics Agency awarded a $1,171.62 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561590969 MYRBETRIQ ER 25 MG TABLET 30S. The single award delivery order was issued against an existing Prime Vendor contract vehicle and has a period of performance from July 25, 2023 through July 26, 2023. Amerisourcebergen will fulfill the order for the pharmaceutical product from its facility in Conshohocken, Pennsylvania to support the Defense Logistics...
- The Defense Logistics Agency awarded a $8,520 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561636417 MYRBETRIQ ER 25 MG TABLET 90S. The delivery order was issued against an existing prime vendor contract vehicle and calls for the contractor to deliver the specified pharmaceutical product to a facility in Conshohocken, Pennsylvania by July 31, 2023. As a leading provider of pharmaceuticals and healthcare value-added services to the Department of...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $20,643.14 to Amerisourcebergen Drug Corporation to supply 4561970776 MYRBETRIQ ER 50 MG tablets. Under the terms of the order, Amerisourcebergen will deliver 90 tablets to a facility in Conshohocken, Pennsylvania, with performance required from August 28 to August 29, 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, Amerisourcebergen will fulfill this order to...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $853.64 to Amerisourcebergen Drug Corporation for the supply of 4561904087 MYRBETRIQ ER 50 MG TABLET 30S. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the specified pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill DLA requirements. Amerisourcebergen Corporation is the identified parent company of Amerisourcebergen Drug Corporation, the prime contractor...
- The Defense Logistics Agency awarded a $11,083 delivery order to Amerisourcebergen Drug Corporation for the supply of 4562019911 MYRBETRIQ ER 50 MG TABLET 90S. The firm fixed price order is being fulfilled under an existing Prime Vendor contract vehicle and will provide pharmaceutical products to support the Department of Defense's medical readiness programs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period concluding on September 1,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,116 to Amerisourcebergen Drug Corporation for the supply of 90 MYRBETRIQ ER 25 MG tablets. Amerisourcebergen Drug Corporation will perform as the prime contractor, with corporate oversight provided by its parent company, Amerisourcebergen Corporation. Performance will take place in Conshohocken, Pennsylvania over a period of one day, from August 7 to August 8, 2023. No set aside designation or...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB23FQ2YPDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $13,213.17 to Amerisourcebergen Drug Corporation for the supply of 4561987022 MYRBETRIQ ER 50 MG TABLET 90S. Amerisourcebergen Drug Corporation will perform as the prime contractor, with corporate oversight provided by its parent company, Amerisourcebergen Corporation. Performance will take place in Conshohocken, Pennsylvania, spanning from August 29, 2023 through August 30, 2023. No set-aside designation or involvement of major subcontractors was indicated. This order is likely placed against DLA's Pharmaceutical Prime Vendor contract to support the medical treatment needs of Department of Defense personnel.
Generated 12/14/23, 10:53 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.2k | 8/29/23 |